ArticleJournal of cellular and molecular medicine2022

Inhibition of TRIM32 by ibr-7 treatment sensitizes pancreatic cancer cells to gemcitabine via mTOR/p70S6K pathway.

Bo Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.